Skip to content

Intraoperative neuromonitoring of neurosurgical patients using a non-invasive tissue-photospectrometry technique

Intraoperative neuromonitoring of neurosurgical patients using a non-invasive tissue-photospectrometry technique

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00013047
Enrollment
100
Registered
2017-10-02
Start date
2013-10-04
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral aneurysm, intracranial hemorrhage, cerebral ischemia, brain edema I67.1 I61.1 I63.9

Interventions

Group 1: A non-invasive combined Laser-Doppler-flowmeter and tissue-spectrophotometer is used in patients undergoing scheduled intracranial surgery (group 1) to record local cerebral microcirculation

Sponsors

Neurochirurgische Klinik, Universitätsklinikum Erlangen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: a) All participants of this study have to be either fully competent or provide a legal guardian for medical concerns b) Written informed consent of the participant or his/her legal guardian c) Age of 18 to 85 years, both genders. d) Depending on the study phase, two groups are investigated: Group 1: Patients undergoing a scheduled neurosurgical operation such as resection of a supra- or infratentorial lesion (meningeoma, vestibular schwannoma, pituitary adenoma, arachnoid cyst) Group 2: Patients with life-threatening neurosurgical disease which requires emergency surgery within 72 hours such as intracranial hemorrhage or brain tumors with mass effect.

Exclusion criteria

Exclusion criteria: a) decompensated liver- or renal disease b) acute coronary syndrome c) severe comorbidity (mRS = 3) d) pregnancy e) last participation in a trial <6 months

Design outcomes

Primary

MeasureTime frame
Primary endpoint (at the time of discharge/ max. 14 days after surgery): death or severe disability according to the modified Rankin Scale (mRS score 4, 5 or 6)

Secondary

MeasureTime frame
Secondary Endpoints (after 3, 6 an 12 months): 1. Median time of survival 2. Degree of disability according the the Karnofsky Perormance Scale or the modified Rankin Scale. 3. Overall mortaility 4. Surgery-related complications

Countries

Germany

Contacts

Public ContactBjörn Sommer

Paracelsus-Klinik Osnabrück, Neurochirurgische Abteilung

bjoern.sommer@paracelsus-kliniken.de00495419663861

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 26, 2026